Showing results (1131-1140 of 1,216) with videos related to

Sort By:
Pageof 122
Arthritis Research & Therapy|July 29, 2025
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)Vasiliki Liakouli, Giulio Forte, Piero Ruscitti, et al.
RMD Open|May 21, 2026
Real-world damage accrual in Sjögren's disease: a 5-year multicentre GIRRCS cohort analysisOnorina Berardicurti, Annalisa Marino, Luca Navarini, et al.
Frontiers in Immunology|July 30, 2024
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritisRoberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Giornale Italiano Di Cardiologia (2006)|February 3, 2026
[Light chain amyloidosis: multidisciplinary management and innovative therapeutic strategies. SIC/ANMCO Consensus document of the Italian Cardiac Amyloidosis Network (RIAC)]Alberto Aimo, Giuseppe Vergaro, Vincenzo Castiglione, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 3, 2026
Early cardiac sympathetic denervation in hereditary transthyretin amyloidosis: 123I-metaiodobenzylguanidine findings and correlation with skin biopsyViviana Frantellizzi, Chiara Cambieri, Eleonora Galosi, et al.
Autoimmunity Reviews|March 23, 2024
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensusFabio Salvatore Macaluso, Flavio Caprioli, Laura Benedan, et al.
Arthritis Research & Therapy|September 28, 2024
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohortRoberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Clinical and Experimental Rheumatology|January 11, 2021
Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational studySalvatore D'Angelo, Nazzarena Malavolta, Cinzia Scambi, et al.
Frontiers in Pharmacology|May 15, 2026
Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritisRoberta Ramonda, Mariagrazia Lorenzin, Antonio Carletto, et al.
Rheumatology (Oxford, England)|April 18, 2026
Phenotypic differences and treatment persistence in a large multicenter cohort of axial psoriatic arthritisGiuseppe Lopalco, Sergio Del Vescovo, Michele Maria Luchetti, et al.
Pageof 122